Teclistamab in patients with multiple myeloma and impaired renal function

被引：11
|
作者：
Joiner, Laura [1 ]
Bal, Susan [2 ]
Godby, Kelly N. [2 ]
Costa, Luciano J. [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Dept Pharm, Birmingham, AL USA
[2] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, 1802 6th Ave South, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 11期
关键词：
D O I：
10.1002/ajh.27063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E322 / E324
页数：3
相关论文
共 50 条
  • [21] RENAL-FUNCTION IN PATIENTS WITH MULTIPLE-MYELOMA
    DEFRONZO, RA
    COOKE, CR
    WRIGHT, JR
    HUMPHREY, RL
    MEDICINE, 1978, 57 (02) : 151 - 166
  • [22] RENAL FUNCTION IN MULTIPLE MYELOMA
    ARMSTRONG, JB
    JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (04): : 768 - 768
  • [23] RENAL FUNCTION IN MULTIPLE MYELOMA
    GOLDMAN, R
    ADAMS, WS
    LUCHSINGER, EB
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1952, 40 (04): : 519 - 522
  • [24] Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience
    Lachenal, Florence
    Lebreton, Pierre
    Bouillie, Sylvie
    Matteo, Gian
    Aftisse, Hassina
    Pascal, Laurent
    Montes, Lydia
    Macro, Margaret
    Vignon, Marguerite
    Harel, Stephanie
    Fernandez, Mariana
    Louni, Chanaz
    Huart, Antoine
    Perrot, Aurore
    BLOOD, 2023, 142
  • [25] The Efficacy of Teclistamab in Multiple Myeloma Patients with Secondary Plasma Cell Leukemia
    Shrestha, Asis
    Thanendrarajan, Sharmilan
    Bag, Aishee
    Dhakal, Binod
    Zangari, Maurizio
    Al Hadidi, Samer
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Chakraborty, Rajshekhar
    Shah, Nishi
    Shah, Mansi R.
    Mohan, Meera
    Schinke, Carolina
    BLOOD, 2024, 144 : 6994 - 6995
  • [26] Teclistamab is safe and effective in relapse refractory multiple myeloma patients with end stage renal disease: a case series
    Hagen, Patrick
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S183 - S183
  • [27] Multiple myeloma: antiresorptive therapy in patients with osteolytic lesions and impaired renal function - data from the MYRIAM registry
    von der Heyde, E.
    Reiser, M.
    Nusch, A.
    Dechow, T.
    Jacobasch, L.
    Zingerle, M.
    Schweizer, C.
    Medinger, T.
    Jaenicke, M.
    Potthoff, K.
    Engelhardt, M.
    Einsele, H.
    Knauf, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 313 - 313
  • [28] Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study
    Mikhael, Joseph
    Manola, Judith
    Dueck, Amylou C.
    Hayman, Suzanne
    Oettel, Kurt
    Kanate, Abraham S.
    Lonial, Sagar
    Rajkumar, S. Vincent
    BLOOD CANCER JOURNAL, 2018, 8
  • [29] Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study
    Joseph Mikhael
    Judith Manola
    Amylou C. Dueck
    Suzanne Hayman
    Kurt Oettel
    Abraham S. Kanate
    Sagar Lonial
    S. Vincent Rajkumar
    Blood Cancer Journal, 8
  • [30] IMPACT OF TREATMENT ON RECOVERY OF RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA
    Da Ros Carolina, Villegas
    Zuluaga Sebastian, Ortiz
    Gonzalez Karla, Javier
    Sofia, Costa
    Rodriguez Pedro, Perez
    Castello Mayte, Orero
    Rosa, Collado
    Pellicer Monica, Roig
    Ramon Felix, Carbonell
    Pavia Maria, Lopez
    Garcia Mariano, Linares
    HAEMATOLOGICA, 2016, 101 : 96 - 97
12345